categories
HOT TOPICS
- The Accelerator Conundrum
- The Startup Velocity Question
- Platform as a Service
- Man and Superman
- Web 3.0 = (4C + P + VS)
- The Future: End of Capitalism
- Capitalism 2.0
inspire
Resilient Entrepreneurship: Inspire CEO Brian Loew (Part 7)
Sramana Mitra: This is actually a great story. I love stories like this. There’s another entrepreneur whose story I’ve covered. For the first four years, he had no revenue. In the fifth year, they had a million dollars in revenue, and in the sixth year, $100 million. If you’re interested, you can check out his
Resilient Entrepreneurship: Inspire CEO Brian Loew (Part 6)
Sramana Mitra: If you have the stomach and the resilience to stick it out, it gives you the ammunition and ability to gather up a lot of competitive advantage. It’s not easy to build up that kind of competitive advantage in a short order. It’s just a matter of time. If you can survive those
Resilient Entrepreneurship: Inspire CEO Brian Loew (Part 5)
Sramana Mitra: In that revenue model, what does an average deal size look like? Brian Loew: I’ll answer that but also, the other part of research that has actually become larger than that is the market research side of it where pharmaceutical companies want to know about patient perspectives on things. Typically, a pharma will
Resilient Entrepreneurship: Inspire CEO Brian Loew (Part 4)
Sramana Mitra: That’s great. In all two-sided marketplaces, the chicken-and-egg problem is huge. The fact that you were able to mitigate that with these non-profit organisations is a great strategy. The counterpart then becomes, what is the business model? Brian Loew: We don’t charge anything for patients. Our customers are pharmaceutical, biotech, and device companies.
